Fourpath Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.52M | Buy |
8,173
+454
| +6% | +$84.3K | 0.24% | 76 |
|
|
2025
Q1 | $1.62M | Buy |
7,719
+293
| +4% | +$61.4K | 0.28% | 71 |
|
|
2024
Q4 | $1.32M | Buy |
7,426
+876
| +13% | +$156K | 0.24% | 81 |
|
|
2024
Q3 | $1.29M | Buy |
6,550
+406
| +7% | +$80.2K | 0.24% | 80 |
|
|
2024
Q2 | $1.05M | Sell |
6,144
-314
| -5% | -$53.9K | 0.78% | 23 |
|
|
2024
Q1 | $1.18M | Sell |
6,458
-2,229
| -26% | -$406K | 0.82% | 23 |
|
|
2023
Q4 | $1.35M | Buy |
8,687
+582
| +7% | +$90.2K | 0.91% | 19 |
|
|
2023
Q3 | $1.21M | Sell |
8,105
-215
| -3% | -$32K | 0.91% | 25 |
|
|
2023
Q2 | $1.12M | Sell |
8,320
-1,231
| -13% | -$166K | 1.35% | 19 |
|
|
2023
Q1 | $1.52M | Sell |
9,551
-456
| -5% | -$72.7K | 1.07% | 15 |
|
|
2022
Q4 | $1.62M | Sell |
10,007
-418
| -4% | -$67.6K | 1.18% | 15 |
|
|
2022
Q3 | $1.4M | Sell |
10,425
-718
| -6% | -$96.4K | 0.96% | 22 |
|
|
2022
Q2 | $1.71M | Sell |
11,143
-3,872
| -26% | -$593K | 1.06% | 17 |
|
|
2022
Q1 | $2.43M | Sell |
15,015
-1,595
| -10% | -$259K | 0.97% | 22 |
|
|
2021
Q4 | $2.25M | Buy |
+16,610
| New | +$2.25M | 0.86% | 20 |
|